Drug Type Small molecule drug |
Synonyms 1-[10-(3-dimethylamino-propyl)-10H-phenothiazin-2-yl]-ethanone, 10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone, 10-(3-dimethylaminopropyl)phenothiazine-3-ethylone + [5] |
Target |
Action antagonists |
Mechanism DRDs antagonists(Dopamine receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22N2OS |
InChIKeyNOSIYYJFMPDDSA-UHFFFAOYSA-N |
CAS Registry61-00-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D07065 | Acepromazine |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Behavioural disorders | - | - | - |





